Stoke Therapeutics STOK
NASDAQ STOK
$25.88 +0.38 (+1.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Operating Margin (2022 - 2026)

Updated

Stoke Therapeutics' Operating Margin came in at -701.65% for Q2 2026, down 504.07 percentage points from -197.58% a year earlier but up 155.92 percentage points from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Operating Margin (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Stoke Therapeutics reported Operating Margin of -809.69%, down 829.84 percentage points year-over-year; for FY2025, it came in at -11.16%, up 266.15 percentage points from FY2024.

  • Operating Margin carries a three-year change of +830.08 percentage points (FY2022 to FY2025).
  • Going back by year, Operating Margin was -277.31% in FY2024 (+1029.90 pp), -1307.21% in FY2023 (-465.97 pp) and -841.24% in FY2022.
  • The five-year range for quarterly Operating Margin is -4382.24% (Q4 2025) to 70.15% (Q1 2025).
  • Year-over-year, Operating Margin has declined for three consecutive quarters, with an average year-over-year change of -398.41 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2024 (a gain of 995.51 percentage points), and the weakest in Q4 2025 (a drop of 4321.87 percentage points).
  • Business Quant data shows STOK's Operating Margin at -857.57% (Q1 2026), -4382.24% (Q4 2025) and -405.30% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Stoke Therapeutics 1.59 Bn 421.92 Mn - -701.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -701.65%
Mar 31, 2026 -857.57%
Dec 31, 2025 -4,382.24%
Sep 30, 2025 -405.30%
Jun 30, 2025 -197.58%
Mar 31, 2025 70.15%
Dec 31, 2024 -60.37%
Sep 30, 2024 -613.06%
Jun 30, 2024 -607.37%
Mar 31, 2024 -672.96%
Dec 31, 2023 -1,055.89%
Sep 30, 2023 -823.28%
Jun 30, 2023 -1,340.67%
Mar 31, 2023 -479.23%
Dec 31, 2022 -831.58%
Sep 30, 2022 -934.53%
Jun 30, 2022 -781.12%
Mar 31, 2022 -826.50%
API Access

Stoke Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=STOK&period=max&api_key=YOUR_API_KEY